Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation

Abstract

Blockage of transcription has been shown to induce the tumor suppressor p53 in human cells. We here show that RNA synthesis inhibitors blocking the phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase II, such as DRB and H7, induced rapid nuclear accumulation of p53 proteins that were not phosphorylated at ser15 or acetylated at lys382. In contrast, agents that inhibit the elongation phase of transcription, such as UV light, camptothecin or actinomycin D, induced the accumulation of nuclear p53 proteins that were modified at both of these sites. Furthermore, using a panel of DNA repair-deficient cells we show that persistent DNA lesions in the transcribed strand of active genes are responsible for the induction of the ser15 and lys382 modifications following UV-irradiation. We conclude that inhibition of transcription is sufficient for the accumulation of p53 in the nucleus regardless of whether the ser15 site of p53 is phosphorylated or not. Importantly, blockage of the elongation phase of transcription triggers a distinct signaling pathway leading to p53 modifications on ser15 and lys382. We propose that the elongating RNA polymerase complex may act as a sensor of DNA damage and as an integrator of cellular stress signals.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • An WG, Chuman Y, Fojo T, Blagosklonny MV . 1998 Exp. Cell. Res. 244: 54–60

  • Ashcroft M, Taya Y, Vousden KH . 2000 Mol. Cell. Biol. 20: 3224–3233

  • Banin S, Moyal L, Shieh SY, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y . 1998 Science 281: 1674–1677

  • Bender K, Blattner C, Knebel A, lordanov M, Herrlich P, Rahmsdorf HJ . 1997 J. Photochem. Photobiol. B: Biol. 37: 1–17

  • Blattner C, Sparks A, Lane D . 1999a Mol. Cell. Biol. 19: 3704–3713

  • Blattner C, Tobiasch E, Litfen M, Rahmsdorf HJ, Herrlich P . 1999b Oncogene 18: 1723–1732

  • Boyd SD, Tsai KY, Jacks T . 2000 Nat. Cell Biol. 2: 563–568

  • Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD . 1998 Science 281: 1677–1679

  • Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD . 1999 Proc. Natl. Acad. Sci. USA 96: 13777–13782

  • Chen AY, Liu LF . 1994 Annu. Rev. Pharmacol. Toxicol. 34: 191–218

  • Christians FC, Hanawalt PC . 1994 Mutat. Res. 323: 179–187

  • Dubois MF, Nguyen VT, Bellier S, Bensaude O . 1994 J. Biol. Chem. 269: 13331–13336

  • Dumaz N, Meek DW . 1999 EMBO J. 18: 7002–7010

  • Fiscella M, Ullrich S, Zambrano N, Shields M, Lin D, Less-Miller S, Anderson C, Mercer W, Apella E . 1995 Oncogene 8: 1519–1528

  • Friedberg E, Walker G, Siede W . 1995 DNA Repair and Mutagenesis ASM Press: Washington, D.C

    Google Scholar 

  • Geyer RK, Yu ZK, Maki CG . 2000 Nat. Cell Biol. 2: 569–573

  • Groulx I, Bonicalzi ME, Lee S . 2000 J. Biol. Chem. 275: 8991–9000

  • Gu W, Roeder RG . 1997 Cell 90: 595–606

  • Hirose Y, Manley JL . 2000 Genes Dev. 14: 1415–1429

  • Hupp T, Sparks A, Lane D . 1995 Cell 83: 237–245

  • Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP . 2001 EMBO J. 20: 1331–1340

  • Koumenis C, Giaccia A . 1997 Mol. Cell. Biol. 17: 7306–7316

  • Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN . 1998 J. Biol. Chem. 273: 33048–33053

  • Le Page F, Kwoh EE, Avrutskaya A, Gentil A, Leadon SA, Sarasin A, Cooper PK . 2000 Cell 101: 159–171

  • Ljungman M . 2000 Neoplasia 2: 208–225

  • Ljungman M, Hanawalt PC . 1996 Carcinogenesis 17: 31–35

  • Ljungman M, Zhang F . 1996 Oncogene 13: 823–831

  • Ljungman M, Zhang FF, Chen F, Rainbow AJ, McKay BC . 1999 Oncogene 18: 583–592

  • Lu X, Burbidge SA, Griffin S, Smith HM . 1996 Oncogene 13: 413–418

  • Marshall NF, Peng JM, Xie Z, Price DH . 1996 J. Biol. Chem. 271: 27176–27183

  • McKay B, Chen F, Clarke S, Wiggin H, Harley L, Ljungman M . 2001 Mutat. Res. 485: 93–105

  • McKay B, Ljungman M . 1999 Neoplasia 1: 276–284

  • McKay BC, Chen F, Perumalswami CR, Zhang FF, Ljungman M . 2000 Mol. Biol. Cell 11: 2543–2551

  • McKay BC, Ljungman M, Rainbow AJ . 1998 Oncogene 17: 545–555

  • Mello JA, Lippard SJ, Essigmann JM . 1995 Biochemistry 34: 14783–14791

  • Mellon I, Spivak G, Hanawalt PC . 1987 Cell 51: 241–249

  • Neish AS, Anderson SF, Schlegel BP, Wei WJ, Parvin JD . 1998 Nucleic Acids Res 26: 847–853

  • Perry M, Piette J, Zawadzki J, Harvey D, Levine A . 1993 Proc. Natl. Acad. Sci. USA 90: 11623–11627

  • Poele RHT, Okorokov AL, Joel SP . 1999 Oncogene 18: 5765–5772

  • Price DH . 2000 Mol. Cell. Biol. 20: 2629–2634

  • Proudfoot N . 2000 Trends Biochem. Sci. 25: 290–293

  • Reinke V, Lozano G . 1997 Radiat. Res. 148: 115–122

  • Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E . 1998 Genes Dev. 12: 2831–2841

  • Sakaguchi K, Saito S, Higashimoto Y, Roy S, Anderson CW, Appella E . 2000 J. Biol. Chem. 275: 9278–9283

  • Sauerbier W, Hercules K . 1978 Annu. Rev. Genet. 12: 329–363

  • She QB, Chen N, Dong Z . 2000 J. Biol. Chem. 275: 20444–20449

  • Shieh SY, Ikeda M, Taya Y, Prives C . 1997 Cell 91: 325–334

  • Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB . 1997 Genes Dev. 11: 3471–3481

  • Sobell H . 1985 Proc. Natl. Acad. Sci. USA 82: 5328–5331

  • Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, Abraham RT . 1999 Genes Dev. 13: 152–157

  • Unger T, Juven-Gershon T, Moallem E, Berger M, Sionov RV, Lozano G, Oren M, Haupt Y . 1999a EMBO J. 18: 1805–1814

  • Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y . 1999b Oncogene 18: 3205–3212

  • Venema J, Vanhoffen A, Karcagi V, Natarajan AT, Vanzeeland AA, Mullenders LHF . 1991 Mol. Cell. Biol. 11: 4128–4134

  • Wang JA, Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM . 1999 Int. J. Radiat. Biol. 75: 301–316

  • Yamaizumi M, Sugano T . 1994 Oncogene 9: 2775–2784

  • Yuan ZM, Huang YY, Ishiko T, Nakada S, Utsugisawa T, Shioya H, Utsugisawa Y, Yokoyama K, Weichselbaum R, Shi Y, Kufe D . 1999 J. Biol. Chem. 274: 1883–1886

Download references

Acknowledgements

We thank Bruce McKay for valuable input and Sara Ljungman for critically reading this manuscript. This work was supported by a grant from the National Institute of Health (CA82376-01).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mats Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, M., O'Hagan, H. & Paulsen, M. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation. Oncogene 20, 5964–5971 (2001). https://doi.org/10.1038/sj.onc.1204734

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204734

Keywords

This article is cited by

Search

Quick links